PHS30 Health Care Costs in Psoriatic Arthritis (PSA) Patients Newly Initiated on a Biologic Disease-Modifying Anti-Rheumatic Drug (DMARDS) or Methotrexate (MTX)

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.1803
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV